Aripiprazole Once-monthly in Patients With Schizophrenia
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
To obtain information on the safety, tolerability and effectiveness of aripiprazole
once-monthly in a manner consistent with its intended use in everyday clinical practice in
patients with schizophrenia who completed Study 14724A / NCT01795547.